Liver Transplantation with Tregs at MGH

(

LITTMUS_MGH

)

ITN Protocol #:

ITN073ST

Branded Name:

LITTMUS_MGH

ClinicalTrials.Gov ID:

NCT03577431

Treatment Protocol #:

Therapeutic Area:

Transplantation

Current Status:

Follow-up

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

A Phase I/II Drug Withdrawal Study of Alloantigen-Specific Tregs in Liver Transplantation

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

James Markmann, MD PhD James.Markmann@pennmedicine.upenn.edu

Work:

215-662-4083

Protocol Chair

Eva Guinan Eguinan@partners.org

Work:

617-632-4932

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-420-4250

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-420-4250

Protocol Chair

Juliete Francisco Da Silva, PhD jsilva@immunetolerance.org

Work:

205-960-1065

Protocol Chair

Tielin Qin

Work:

(240) 235-6139

Protocol Chair

Sindhu Chandran, MD schandran@immunetolerance.org

Work:

415-610-4284

Protocol Chair

Yvonne Morrison, MS yvonne.morrison@nih.gov

Work:

240-627-3577

Protocol Chair

Theresa Scocca Theresa_Scocca@rhoworld.com

Work:

919-595-6312

Protocol Chair

Emily Kirkby Emily.Kirkby@ppd.com

Work: